📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

An HLA-E-targeted TCR bispecific molecule redirects T cell immunity against Mycobacterium tuberculosis. (2024)

First Author: Paterson RL

Attributed to: Investigating local determinants of outcome in human tuberculosis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1073/pnas.2318003121

PubMed Identifier: 38691588

Publication URI: http://europepmc.org/abstract/MED/38691588

Type: Journal Article/Review

Volume: 121

Parent Publication: Proceedings of the National Academy of Sciences of the United States of America

Issue: 19

ISSN: 0027-8424